Evan BartholomeuszThis was a randomized, double-blind, placebo-controlled clinical trial evaluating whether D-cycloserine improves the antidepressant effects of intermittent theta burst stimulation when administered immediately before each TMS session.
Evan BartholomeuszThe THREE-D trial is the largest randomized controlled trial comparing intermittent theta burst stimulation to standard high-frequency rTMS for major depressive disorder.
Evan BartholomeuszThe ONE-D study is the first published clinical trial evaluating a complete course of accelerated iTBS delivered in a single day, augmented with D-cycloserine to enhance neuroplasticity throughout treatment.
Evan BartholomeuszWhat this study was - The Stanford Neuromodulation Therapy trial commonly called the SAINT study or SNT trial is the most rigorous published evaluation of accelerated iTBS for treatment-resistant depression.